KZR vs NVST · $53.9M cap vs P/E 56, rev $1.44B
Kezar Life Sciences Inc (KZR) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
KZR currently screens at market cap $53.9M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the KZR and NVST stock pages for the full models.
Not investment advice.